Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma 9. Oktober 2023 Kümmerl, L., Kraulich, M., Lesyuk, W., Binninger, A., Goebell, P.J., Kahlmeyer, A., 2023. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2023.06.011 Link Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma. Kümmerl, L., Kraulich, M., Lesyuk, W., Binninger, A., Goebell, P.J., Kahlmeyer, A., 2023. Urologic Oncology: Seminars and Original Investigations. https://doi.org/10.1016/j.urolonc.2023.06.011 Link… Weiterlesen Risk score assessment in clinical routine including gene expression testing – Interim Results of the non-interventional study PERFORM evaluating Palbociclib in Combination with Endocrine Therapy for HR+/HER2- Advanced Breast Cancer Fietz T., Radosa J., Wilke J., Decker T., Petersen V., Deryal M., Knoblich, J., Losem, C., Rhein U., Schöttker B., Wrobel D., Cubas Cordova M.,… Weiterlesen